title: Experimental therapeutics in prostate cancer: where are we now and where do we need to go.
authors.affiliation: Laborde Professor for Cancer Research, Departments ofMedicine and Urology, Tulane Medical School, New Orleans, LA 70112, USA. osartor@tulane.edu
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D018450:Disease Progression; D055808:Drug Discovery; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
chemical_list: D018931:Antineoplastic Agents, Hormonal; D019496:Cancer Vaccines